Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis

Kidney International

Volumn 53, Issue 4, 1998, Pages 994-1001

  De Sain Van Der Velden, Monique G ^b   Kaysen, George A ^b   Barrett, Hugh A ^b   Stellaard, Frans ^b   Gadellaa, Mireille M ^b   Voorbij, Hieronymus A ^b   Reijngoud, Dirk Jan ^b   Rabelink, Ton J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

Albumin; Apo B100; Lipoproteins and nephrotic syndrome; Nephrotic syndrome; Stable isotopes

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; CARBON 13; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VALINE; VERY LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CATABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN METABOLISM; LIPOPROTEIN SYNTHESIS; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL;

EID: 0031979035     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.1998.00831.x     Document Type: Article

References (44)

1. KAYSEN GA: Hyperlipidemia of the nephrotic syndrome. Kidney Int 31(Suppl):S8-S15, 1991
2. WARWICK GL, PACKARD CJ, DEMANT T, BEDFORD DK, BOULTON-JONES JM, SHEPHERD J: Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria. Kidney Int 40:129-138, 1991
3. VEGA GL, GRUNDY SM: Lovastatin therapy in nephrotic hyperlipidemia: Effects on lipoprotein metabolism. Kidney Int 33:1160-1168, 1988
4. WARWICK GL, CASLAKE MJ, BOULTON JONES JM, DAGEN M, PACKARD CJ, SHEPHERD J: Low-density lipoprotein metabolism in the nephrotic syndrome. Metabolism 39:187-192, 1990
5. AGUILAR SALINAS CA, BARRETT PH, KELBER J, DELMEZ J, SCHONFELD G: Physiologic mechanisms of action of lovastatin in nephrotic syndrome. J Lipid Res 36:188-194, 1995
6. KEANE WF, MULCAHY WS, KASISKE BL, KIM Y, O'DONNELL MP: Hyperlipidemia and progressive renal disease. Kidney Int 39(Suppl): S41-S48, 1991
7. KASISKE BL, O'DONNELL MP, COWARDIN W, KEANE WF: Lipids and the kidney. Hypertension 15:443-450, 1990
8. KEANE WF, O'DONNELL MP, KASISKE BL, SCHMITZ PG: Lipids and the progression of renal disease. J Am Soc Nephrol 1(Suppl):S69-S74, 1990
9. OHTA T, MATSUDA I: Lipid and apolipoprotein levels in patients with nephrotic syndrome. Clin Chim Acta 117:133-143, 1981
10. APPEL GB, BLUM CB, CHIEN S, KUNIS CL, APPEL AS: The hyperlipidemia of the nepfrotic syndrome. Relation to plasma albumin concentration, oncotic pressure, and viscosity. N Engl J Med 312:1544-1548, 1985
11. PARHOFER KG, BARRETT PHR, BIER DM, SCHONFELD G: Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes. J Lipid Res 32:1311-1323, 1991
12. COHN JS, WAGNER DA, COHN SD, MILLAR JS, SCHAEFER EJ: Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding. J Clin Invest 85:804-811, 1990
13. SUN X, KAYSEN GA: Albumin and transferrin synthesis are increased in H4 cells by serum from analbuminemic or nephrotic rats. Kidney Int 45:1381-1387, 1994
14. LEWANDOWSKI AF, LIAO WSL, STINSON-FISHER CA, KENT JD, JEFFERSON LS: Fffects of experimentally induced nephrosis on protein synthesis in rat liver. Am J Physiol 254:C634-C642, 1988
15. KAYSEN GA: Albumin metabolism in the nephrotic syndrome: the effect of dietary protein intake. Am J Kidney Dis 12:461-480, 1988
16. BALLMER PE, WEBER BK, ROY CHAUDHURRY P, MCNURIAN MA, WATSON H, POWER DA, GARLICK PJ: Elevation of albumin synthesis rates in nephrotic patients measured with leucine. Kidney Int 41:132-138, 1992
17. KAYSEN GA, GAMBERTOGLIO J, JIMENEZ I, JONES H, HUTCHISON FN: Effect of dietary protein intake on albumin homeostasis in nephrotic patients. Kidney Int 29:572-577, 1986
18. DE SAIN-VAN DER VELDEN MGM, KAYSEN GA, DE MEER K, STELLAARD F, VOORBIJ HAM, REIJNGOUD DJ, RABELINK TJ, KOOMANS HA: Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients. Measurements with stable isolopes. Kidney Int (in press)
19. MARSH JB, SPARKS CE: Hepatic secretion of lipoproteins in the rat and the effect of experimental nephrosis. J Clin Invest 64:1229-1237, 1979
20. DAVIS RA, ENGELHORN SC, WEINSTEIN DB, STEINBERG D: Very low density lipoprotein secretion by cultured rat hepatocytes. Inhibition by albumin and other macromolecules. J Biol Chem 255:2039-2045, 1980
21. 131-labelled human serum albumin in man. J Clin Invest 32:138-148, 1953
22. PEKELHARING HLM, KLEINVELD HA, DUIE PFCCM, BOUMA BN, VAN RIJN HJM: Effect of lipoprotein(a) and LDL on plasminogen binding to extracellular matrix and on matrix-dependent plasminogen activation by tissue plasminogen activator. Thromb Haemost 75:497-502, 1996
23. EGUSA G, BRADY DW, GRUNDY SM, HOWARD BV: Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B. J Lipid Res 24:1261-1267, 1983
24. HILL RL: Hydrolysis of proteins. Advantages of Prot Chem 20:37-107, 1965
25. REDGRAVE TG, ROBERTS DCK, WEST CE: Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem 65:42-49, 1975
26. VÄISÄNEN S, GÄVERT J, JULKUNEN A, VOUTILAINEN E, PENTTILÄ I: Contents of apolipoprotein A-I, A-II and B of the human serum fractions for high-density and low-density lipoproteins prepared by common precipitation methods. Scand J Clin Lab Invest 52:853-862, 1992
27. HUSEK P: Rapid derivatization and gas chromatographic determination of amino acids. J Chromatogr 552:289-299, 1991
28. SAAM II User Guide. Seattle, University of Washington
29. FOSTER DM, BARRETT PHR, TOFFOLO G, BELTZ WF, COBELLI C: Estimating the fractional synthetic rate of plasma apolipoproteins and lipids from stable isotope data. J Lipid Res 34:2193-2205, 1993
30. FURUKAWA S, HIRANO T, MAMO JCL, NAGANO S, TAKAHASHI T: Catabolic defect of triglyceride is associated with abnormal very-low-density lipoprotein in experimental nephrosis. Metabolism 39:101-107, 1990
31. YAMADA M, MATSUDA I: Lipoprotein lipase in clinical and experimental nephrosis. Clin Chim Acta 30:787-794, 1970
32. CHAN MK, PERSAUD JW, VARGHESE Z, MOORHEAD JF: Post-heparin hepatic and lipoprotein lipase activities in nephrotic syndrome. Aust NZ J Med 14:841-847, 1984
33. DAVIES RW, STAPRANS I, HUTCHISON FN, KAYSEN GA: Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat. J Clin Invest 86:600-605, 1990
34. TAKAHASHI S, KAWARABAYASI Y, NAKAI T, SAKAI J, YAMAMOTO T: Rabbit very low density lipoprotein receptor: A low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci USA 89:9252-9256, 1992
35. LIANG KH, VAZIRI ND: Acquired VLDL receptor deficiency in experimental nephrosis. Kidney Int 51:1761-1765, 1997
36. PULLINGER CR, NORTH JD, TENG BB, RIFICI VA, RONHILD DE BRITO AE, SCOTT J: The apolipoprotein B gene is constitutively expressed in HepG2 cells: Regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res 30:1065-1077, 1989
37. KAYSEN GA, JONES H JR, MARTIN V, HUTCHISON FN: A low-protein diet restricts albumin synthesis in nephrotic rats. J Clin Invest 83:1623-1629, 1989
38. CIANFLONE K, VU H, ZHANG Z, SNIDERMAN AD: Effects of albumin on lipid synthesis, apo B-100 secretion, and LDL catabolism in HepG2 cells. Atherosclerosis 107:125-135, 1994
39. APPEL G: Lipid abnormalities in renal disease. Kidney Int 39:169-183, 1991
40. BERGESIO F, MONZANI G, CIUTI R, SERRUTO A, BENUCCI A, FRIZZI V, SALVADORI M: Lipids and apolipoproteins change during the progression of chronic renal failure. Clin Nephrol 38:264-270, 1992
41. DIAMOND JR, KARNOVSKY MJ: Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. Kidney Int 33:917-924, 1988
42. SAMUELSSON O, AURELL M, KNIGHT-GIBSON C, ALAUPOVIC P, ATTMAN P: Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron 63:279-285, 1993
43. KEANE WF: Lipids and the kidney. (Perspectives in Clinical Nephrology) Kidney Int 46:910-920, 1994
44. SATO H, SUZUKI S, KOBAYASHI H, OGINO S, INOMATA A, ARAKAWA M: Immunohistological localization of apolipoproteins in the glomeruli in renal disease: Specifically apoB and apoE. Clin Nephrol 36:127-133, 1991